Target intelligence / Profile preview

T-cell receptor recognizing Dolichovespula maculata venom peptides presented by MHC (TCR)

Target
TCR
Molecular classification
Receptor, Antigen-recognizing receptor
01

Overview

The T-cell receptor (TCR) recognizing Dolichovespula maculata (white-faced hornet) venom peptides is a heterodimeric surface protein essential for the recognition of hornet allergens presented by Major Histocompatibility Complex (MHC) molecules (Janeway et al., Immunobiology, 2001). In sensitized individuals, these TCRs primarily interact with peptides derived from major allergens like Dol m 5 (Antigen 5) and Dol m 1 (Phospholipase A1) (WHO/IUIS Allergen Nomenclature Sub-Committee, 2024). This interaction initiates a Th2-polarized immune response, leading to the production of allergen-specific IgE and the potential for systemic anaphylaxis upon subsequent stings (Golden, J. Allergy Clin. Immunol., 2005). Therapeutically, this TCR is the target of venom immunotherapy (VIT), which utilizes standardized venom extracts to induce immune tolerance (Bousquet et al., J. Allergy Clin. Immunol., 1987). The mechanism involves shifting the T-cell response from a Th2 profile to a Th1 or regulatory T-cell (Treg) profile, characterized by increased production of IL-10 and TGF-beta (Akdis et al., J. Clin. Invest., 1998). Successful modulation of this target results in a shift from an allergic Th2 profile to a protective Th1 or Treg profile, significantly reducing the risk of life-threatening reactions upon future stings (Ruëff et al., Allergy, 2005).

Other names
White-faced hornet venom TCRDol m 5-specific T-cell receptorDol m 1-specific T-cell receptorHornet venom-specific T-cell receptor
02

Biological functions

Immune responseSignal transductionAntigen recognition
03

Disease associations

InflammationOther
04

Safety considerations

Systemic allergic reactionsAnaphylaxisInjection site reactions
05

Interacting drugs

Dolichovespula maculata venom extract

2 more in the full profile.

06

Biomarkers

Allergen-specific IgEAllergen-specific IgG4Basophil activation test (BAT)IL-10 levels

Beyond the preview

Go deeper on T-cell receptor recognizing Dolichovespula maculata venom peptides presented by MHC (TCR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell receptor recognizing Dolichovespula maculata venom peptides presented by MHC (TCR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call